PEDIATRICS Vol. 88 No. 5 November 1991, pp. 913-917
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beck, S. A.
Right arrow Articles by Burks, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beck, S. A.
Right arrow Articles by Burks, A. W.

Egg Hypersensitivity and Measles-Mumps-Rubella Vaccine Administration

Suzanne A. Beck MD1, Larry W. Williams MD1, M. Annette Shirrell BSN1, and A. Wesley Burks MD1

1 The University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock

Because reports have described egg-sensitive individuals in whom anaphylaxis developed after measles vaccination, current recommendations include delaying administration of egg-derived vaccines until skin testing can be performed. Specifically, the 1988 Red Book recommends skin testing via scratch, prick, or puncture with 1:10 dilution of the vaccine and, if the result is negative, intradermal testing is suggested. The purpose of this study was to evaluate the likelihood of reaction to measles-mumps-rubella (MMR) vaccine in patients with documented egg sensitivity and to delineate the efficacy of skin-prick testing (SPT) to MMR as a predictor of hypersensitivity to the vaccine. Egg sensitivity was documented by initial SPT to egg and then, if possible, double-blind placebo-controlled food challenge (DBPCFC). Patients with a positive DBPCFC to egg or a history of anaphylactic egg sensitivity had a SPT with the MMR vaccine and then were given the MMR vaccine. Additionally, children with atopic dermatitis who had been previously proven egg sensitive via DBPCFCs were evaluated retrospectively for sensitivity to the MMR vaccine. Sixteen children with a history of egg sensitivity underwent SPT to egg, with a positive result 3 mm greater than the negative control found in 12 patients. Eight of these children had a positive DBPCFC to egg. The SPT to MMR vaccine was negative in all 16 children; vaccine administration followed with no resultant systemic problems. Three children had a local reaction at the site of injection. Twelve additional children with atopic dermatitis and egg sensitivity were reviewed. Each child had a positive SPT and DBPCFC to egg. Ten of these children received the MMR vaccine prior to the time that their egg sensitivity was elucidated. Two other children were vaccinated elsewhere after they were documented egg sensitive. All 12 of these children tolerated the vaccine without incident. These results further substantiate the safety of MMR administration in egg-sensitive children and support routine vaccination of children who do not exhibit systemic allergic hypersensitivity to egg. It is suggested that SPT is an adequate screening method for children with anaphylactic egg sensitivity.

Key Words: measles-mumps-rubella vaccine • egg sensitivity • anaphylaxis • double-blind placebo-controlled food challenge • skin-prick testing

Submitted on July 30, 1990
Accepted on November 12, 1990




This article has been cited by other articles:


Home page
 PediatricsHome page
A. Patja, S. Mäkinen-Kiljunen, I. Davidkin, M. Paunio, and H. Peltola
Allergic Reactions to Measles-Mumps-Rubella Vaccination
Pediatrics, February 1, 2001; 107(2): 27e - 27.
[Abstract] [Full Text]

Home page
 BMJHome page
G A Khakoo and G Lack
Recommendations for using MMR vaccine in children allergic to eggs
BMJ, April 1, 2000; 320(7239): 929 - 932.
[Full Text]

Home page
 Arch. Dis. Child.Home page
R LAKSHMAN and A. FINN
MMR vaccine and allergy
Arch. Dis. Child., February 1, 2000; 82(2): 93 - 95.
[Full Text]

Home page
 NEJMHome page
J. M. James, A. W. Burks, P. K. Roberson, and H. A. Sampson
Safe Administration of the Measles Vaccine to Children Allergic to Eggs
N. Engl. J. Med., May 11, 1995; 332(19): 1262 - 1266.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
R Aickin, D Hill, and A Kemp
Measles immunisation in children with allergy to egg
BMJ, July 23, 1994; 309(6949): 223 - 225.
[Abstract] [Full Text]